A. Jeyakumar

The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer: a systematic review and meta-analysis

T. Younis, Kim Anderson, P. O'Brien, 2019, Breast Cancer Research and Treatment.

Eastern Canadian Colorectal Cancer Consensus Conference 2017.

S. Welch, P. Kavan, D. Jonker, 2018, Current oncology.

Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy.

J. Bendell, T. Alcindor, P. Tang, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019

M. Lock, S. Welch, S. Singh, 2021, Current oncology.

Trastuzumab Beyond Progression for HER2 Positive Metastatic Breast Cancer: Progression‐Free Survival on First‐Line Therapy Predicts Overall Survival Impact

D. Rayson, T. Younis, G. Walsh, 2014, The breast journal.

Incidence of febrile neutropenia during adjuvant chemotherapy for breast cancer: a prospective study.

D. Rayson, T. Younis, A. Jeyakumar, 2012, Current oncology.

Routine cardiac evaluation in patients with early-stage breast cancer before adjuvant chemotherapy.

D. Rayson, T. Younis, K. Thompson, 2012, Clinical breast cancer.

Review of Nasopharyngeal Carcinoma

A. Jeyakumar, T. Brickman, T. Doerr, 2006, Ear, nose, & throat journal.

Eastern Canadian Colorectal Cancer Consensus Conference: standards of care for the treatment of patients with rectal, pancreatic, and gastrointestinal stromal tumours and pancreatic neuroendocrine tumours.

S. Gill, S. Welch, J. Biagi, 2013, Current oncology.

Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations

T. Younis, A. Jeyakumar, 2012, Clinical Medicine Insights. Oncology.